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httpIntroduction: We present a ‘post-close’ technique using the Angio-Seal VIP vascular closure device (VCD) after
percutaneous endovascular aneurysm repair (p-EVAR) using an ultra-low-proﬁle (ULP) device.
Technique: Following percutaneous using an ULP device (here the Ovation Prime system, Trivascular, Eysins,
Switzerland), contralateral femoral hemostasis is achieved by using an ‘undersized’ application of an 8F Angio-
Seal VIP vascular closure device (VCD) for all punctures wherein upto 12F sheaths have been applied for access.
On the ipsilateral side, following ‘double-wire’ preparation, synchronous deployment of an 8F and 6F Angio-Seal
VIP VCDs achieves hemostasis. Procedural heparin is reversed as an adjunct, pressure dressings are applied and
the patient kept ﬂat for 2 hours.
Discussion: Double-wire VCD deployments, and ‘post-close’ techniques have not been described in the context of
femoral hemostasis after p-EVAR. This technique is easy to apply and saves time (and potentially cost) used to set
up ‘pre-close’ devices, as is typically used these days.
 2015 The Author. Published by Elsevier Ltd on behalf of European Society for Vascular Surgery. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Percutaneous femoral access for endovascular aneurysm
repair (EVAR) is increasingly becoming the norm, with
femoral arterial defects now typically closed using vascular
closure devices (VCDs). Such minimally invasive access has
the perceived advantage of minimising groin trauma,1 with
reduced operating time,2 reduced pain,1 early discharge3
and reduction of post-surgical complications,3 with early
return to activity.1 We describe, along with a technical
video, the use of a plug-based vascular closure device,
namely the Angio-Seal VIP (St. Jude Medical, Minnetonka,
MN, USA; hereafter referred to as the Angio-Seal), in
effecting ‘post-close’ femoral hemostasis after percuta-
neous EVAR (p-EVAR).
TECHNIQUE
Following p-EVAR typically using an ultra-low-proﬁle (ULP)
device such as the Ovation Prime (Trivascular, Eysins,
Switzerland), the sheath of the contralateral limb is left in
after deployment if 12F; if a 14F proﬁle contralateral limb is
used this is removed and the femoral defect ‘downsized’
using a 12F sheath. The ipsilateral sheath (device body) is
removed and replaced with a 14F Dry-Seal sheath (WL Gorel.: þ44 1234 355122.
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://dx.doi.org/10.1016/j.ejvssr.2015.10.001& Associates, Inc., Medical Products Division, Flagstaff, AZ,
USA) to facilitate passage of 14F ipsilateral limbs and
minimise sheath exchanges. A second wire, typically a
Bentson (Merit Medical, Jordan, Utah, USA) or Glidewire
Advantage (Terumo Medical Corp., Somerset, NJ, USA), is
then para-axially introduced alongside the procedural Lun-
derquist wire in the ipsilateral 14F sheath [Video 1].
Supplementary video [Video 1] related to this article can
be found at http://dx.doi.org/10.1016/j.ejvssr.2015.10.001.
Firstly, for all contralateral punctures, an 8F Angio-Seal is
deployed over the procedural Lunderquist wire left in
[Video 1]. Supplementary post-deployment manual
compression is required for at least 1 minute as per the IFU,
and the author suggests even a little longer as these are
large holes in heparinised patients compared to those made
in the more typical scenario e.g. lower limb angioplasty;
even though there is visible hemostasis at 1e2 minutes,
100% hemostasis time is up to 10 minutes.4 Next, for
double VCD deployments on the ipsilateral side, an 8F
Angio-Seal is ﬁrst deployed over the Lunderquist wire, and
then a 6F Angio-Seal over the para-axial wire [Video 1]. The
key to avoiding dislodgement of the ﬁrst ipsilateral VCD is to
maintain traction on the foot plate of the 8F Angioseal and
continued tamping of the collagen plug (which can be un-
dertaken by an assistant) whilst the 6F Angio-Seal is being
deployed. Furthermore the lower proﬁle and gradual taper
of the tip allows the 6F device to be introduced alongside
the previous device with no dislodgement of the 8F
Angioseal in either the footplate or plug component.
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with protamine. Pressure dressings, including pneumatic
pressure dressings are applied on the patient’s groins (to be
removed the next morning) and the patient kept ﬂat for two
hours.DISCUSSION
The Angio-Seal consists of a suture-tethered extravascular
collagen plug and an anchoring LP intravascular footplate
which is designed to dissolve in 90 days. The plug is
pushed into place to cover the arterial puncture with
counter-traction at the anchor via the thread, creating an
“anchor-arteriotomy-collagen plug sandwich”. It is easy to
use, and the deployment technique has been previously
described.4 We have extensive experience with use of the
Angio-Seal device, including using it in ‘undersized’ sce-
narios i.e. where the labelled VCD proﬁle is smaller than
the proﬁle of the endovascular device used prior.5 Our
own experience and prior description of the ‘double-wire’
technique6 was the background in applying this ‘post-
close’ technique. In the current scenario we see no real
limitations to using it as such, as the foot plate clearly
locks onto the intimal surface of the femoral artery,
allowing tamping of the collagen plug into place. An 8F
Angio-Seal will therefore easily seal a 12F defect, and it is
standard practice in our peripheral interventional experi-
ence to close such femoral punctures with the 8F Angio-
Seal. Operators will be aware that it is clearly notable at
open access that the defect in a pliable artery shrinks
down once the endograft body/sheath has been removed,
and no doubt this is what allows the Angio-Seal anchor to
‘hold’ from within the arterial lumen, and this is the key to
successful deployment in this scenario. We would also
reiterate that such deployments are off-label.
Other techniques include a ‘pre-close’ approach using a
suture mediated closure device (SMCD) such as the Per-
close ProGlide Suture-Mediated Closure System (Abbott
Vascular, Abbott Park, Illinois, USA; hereafter referred to
as the ProGlide). Typically, for a pre-closed p-EVAR, 4
ProGlides are deployed (2 per groin, as per the IFU for
‘large hole’ access), costing V506.50; comparatively, two
8F and one 6F Angio-Seal cost V368.70 in total, resulting
in a cost saving of V13 780 per 100 patients. An additional
advantage is the procedural time gained in not having to
set up as for pre-close devices. Post-closure techniques
that preclude use of a VCD include the fascial stitch
technique7 which is limited by contraindications such as
the need to increase incision size, the unacceptably high
rates of complications including pseudoaneurysm forma-
tion, and contraindications such as high bifurcation, pre-
vious surgery, and inadvertent high puncture that limit its
application. In this context, as long as there is wire access
the author would advocate Angio-Seal deployment is
feasible even in a high puncture. The author’s femoral
punctures are all ultrasound-located so this should really
not happen but is not felt to be a major issue if it does. As
for previously operated groins, access through a scarredgroin is of course an issue but once achieved we do not
have problems deploying an Angio-Seal. This is potentially
due to the fact the Angio-Seal is deployed along the track
already created and does not need to be rotated within a
ﬁbrotic ﬁeld as would be required for the 10 o’clock and 2
o’clock positioning needed for double ProGlide deploy-
ment. The ProGlide needs to traverse arterial and likely
scar tissue for needle passage and suture delivery which is
not required with the Angio-Seal. It is precisely in such a
scenario that the Angio-Seal has been used as a bail-out
post-close adjunct for incomplete hemostasis after use
of ProGlides.8
Similar technical and indication-related considerations
arise in the obese patient. Firstly, obesity is not a
contraindication in this scenario, and was reported only as
a factor affecting antegrade deployments.9 Secondly, an
issue that seems to cause failed deployments in obese
patients is to do with the lack of stiffness of the Angio-Seal
sheath which tends to buckle once the introducer is
removed if the device is maintained at a right angle, which
then results in the inability to introduce the plug delivery
system. Therefore, if the delivery/sheath angle is made
more shallow while introducing the plug delivery system,
sheath buckling can be minimised (an assistant can sup-
port the device as indicated in video 1) allowing for suc-
cessful deployment, and we have indeed done undertaken
successful deployment with patient BMI of 40. This is an
aspect that needs particular attention especially in the
contralateral groin where just one 8F Angioseal is
deployed with no fallback options (unless a double wire is
also established there for safety, which would then add to
procedural time).
A post-close technique using an anchored collagen plug-
based VCD, namely the Angio-Seal VIP, is entirely feasible
for femoral arterial haemostasis, including synchronous
‘double-wire’ deployments following p-EVAR using an ULP
device. This is now my default technique in this scenario.ACKNOWLEDGEMENTS
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